However, similarlyto HLA-DR/DQ/DP, no significant results were found for any PFN1+ EV subpopulation between newly diagnosed and HD subjects,thus restricting the use of this antigen as a biomarker. The gene discussed is PFN1; the disease is Huntington disease.